DoD invests in medical swab production
The US Department of Defense (DoD) has awarded Puritan Medical Products a $75.5 million investment as part of the Defence Production Act Title 3 funding.
This investment will increase swab production by 20 million units per month from May 2020 onwards and will fund a new manufacturing facility in Pittsfield, Maine. As a result, the company will be capable of expanding output to 40 million medical swabs each month.
In addition, the company will expand its workforce by employing an extra 150 people to work at the new Pittsfield site, according to Lt Col Mike Andrews, a spokesperson at the DoD.
More from Defence Notes
-
![UK urged to prioritise sea, air and space over heavy armour]()
UK urged to prioritise sea, air and space over heavy armour
A report from the Council on Geostrategy argues the UK should move away from a traditional balanced force and shift investment to naval, air and space capabilities, backed by a larger fleet of attack submarines and deeper AUKUS integration.
-
![Thales: deployment speed to determine winners in ‘production versus production’ era]()
Thales: deployment speed to determine winners in ‘production versus production’ era
At its technology summit in London, attended by Shephard, Thales UK examined the importance of speed to delivery, the growing focus on cross-domain capabilities and how procurement reform could be crucial for future battlefield advantage.
-
![Orchestrating operational readiness across every defence domain]()
Orchestrating operational readiness across every defence domain
Are all systems ready for the next mission? Have upgrades been applied? Are all assets aligned to deploy together, on time and fully prepared? In modern defence operations, readiness is no longer measured platform by platform. It is measured by how well people, assets, data and decisions move together — across land, sea and air.
